Dual cancer-specific targeting strategy cures primary and distant breast carcinomas in nude mice.
about
Developing an effective gene therapy for prostate cancer: New technologies with potential to translate from the laboratory into the clinicTherapy of prostate cancer using a novel cancer terminator virus and a small molecule BH-3 mimeticRecombinant interleukin-24 lacks apoptosis-inducing properties in melanoma cells.Cisplatin enhances protein kinase R-like endoplasmic reticulum kinase- and CD95-dependent melanoma differentiation-associated gene-7/interleukin-24-induced killing in ovarian carcinoma cellsPotent anti-tumor effects of a dual specific oncolytic adenovirus expressing apoptin in vitro and in vivoChemical modification with high molecular weight polyethylene glycol reduces transduction of hepatocytes and increases efficacy of intravenously delivered oncolytic adenovirusRecognition-mediated activation of therapeutic gold nanoparticles inside living cellsEradication of therapy-resistant human prostate tumors using an ultrasound-guided site-specific cancer terminator virus delivery approach.Characterization of the canine mda-7 gene, transcripts and expression patterns.Tumour suppressor function of MDA-7/IL-24 in human breast cancerThe development of MDA-7/IL-24 as a cancer therapeuticTumor-specific imaging through progression elevated gene-3 promoter-driven gene expressionIn vivo gene delivery by embryonic-stem-cell-derived astrocytes for malignant gliomas.Construction of doxycyline-dependent mini-HIV-1 variants for the development of a virotherapy against leukemiasEnhanced prostate cancer gene transfer and therapy using a novel serotype chimera cancer terminator virus (Ad.5/3-CTV).Targeting breast cancer-initiating/stem cells with melanoma differentiation-associated gene-7/interleukin-24.Chapter One---Cancer terminator viruses and approaches for enhancing therapeutic outcomes.Gene Therapies for Cancer: Strategies, Challenges and Successes.mda-7/IL-24: a unique member of the IL-10 gene family promoting cancer-targeted toxicity.Enhanced delivery of mda-7/IL-24 using a serotype chimeric adenovirus (Ad.5/3) in combination with the Apogossypol derivative BI-97C1 (Sabutoclax) improves therapeutic efficacy in low CAR colorectal cancer cellsmda-7/IL-24: multifunctional cancer-specific apoptosis-inducing cytokineStrategy for reversing resistance to a single anticancer agent in human prostate and pancreatic carcinomasConditionally replicating adenoviruses for cancer treatment.MDA-7/IL-24: multifunctional cancer killing cytokineIonizing radiation enhances adenoviral vector expressing mda-7/IL-24-mediated apoptosis in human ovarian cancer.Oncolytic adenovirus armed with IL-24 inhibits the growth of breast cancer in vitro and in vivo.MDA-7/IL-24 functions as a tumor suppressor gene in vivo in transgenic mouse models of breast cancer.Suppression of Her2/Neu mammary tumor development in mda-7/IL-24 transgenic miceCD47-retargeted oncolytic adenovirus armed with melanoma differentiation-associated gene-7/interleukin-24 suppresses in vivo leukemia cell growthMelanoma differentiation associated gene-7/interleukin-24 (mda-7/IL-24): novel gene therapeutic for metastatic melanoma.Autocrine regulation of mda-7/IL-24 mediates cancer-specific apoptosis.Melanoma differentiation associated gene-7 (mda-7)/IL-24: a 'magic bullet' for cancer therapy?mda-7/IL-24 Induces Cell Death in Neuroblastoma through a Novel Mechanism Involving AIF and ATM.Histone deacetylase inhibitors interact with melanoma differentiation associated-7/interleukin-24 to kill primary human glioblastoma cells.Combinatorial strategies based on CRAd-IL24 and CRAd-ING4 virotherapy with anti-angiogenesis treatment for ovarian cancer.Selected approaches for rational drug design and high throughput screening to identify anti-cancer moleculesIL-24: a classic cytokine and/or a potential cure for cancer?Armed replicating adenoviruses for cancer virotherapy.Clinical applications of mouse models for breast cancer engaging HER2/neu.Conditionally replicating adenoviruses carrying mda-7/IL-24 for cancer therapy.
P2860
Q27694606-F5B70C81-17B7-46C7-A46E-095DF4C10AE5Q30300019-AD6DCD7B-96B5-4674-BD14-57951860E660Q33309944-B0208CE6-927A-4914-B05E-281A27BD0A30Q33613377-6B3E9535-A28B-410A-A3EE-8638BF36142EQ33638956-D9CE0FFA-7381-4904-8CB3-75D314ABAFF3Q33690982-446BBA7A-185F-467F-925E-25CAE59198F5Q33725235-FB582012-7005-4F7A-B5A2-631DC06CF941Q33730689-5FB9EF97-93B5-425A-BD8E-3BB41D71E3E2Q34040220-CF001436-4E1D-4AA4-BE59-6BF0B35E0841Q34114046-5301A6D3-D2CF-4668-8757-3CDDD03B118EQ34163896-7310BC05-042B-4F3F-B80F-13A2BEF8B337Q34674065-F541C18F-2658-49B5-B365-B4E5F1FAE813Q34803686-9670BE68-FF2F-439F-A33A-38E87C2CC6A3Q35070255-8B0AC722-1210-49AA-A348-A8AD3DA8E10AQ35095082-215679B8-4922-4824-9ED3-BEAEC4019DF5Q35101122-EC98867F-8AE2-4883-A87D-790ACE3A5F19Q35142325-CA30D399-8FF6-4D98-A09B-89F6F81FB2C8Q35186312-53F25FAA-DF66-4701-ADBC-6F44D185333EQ35189796-D7A4FBD0-5685-4B20-933A-4AEE5BC06314Q35587169-9E16D85B-EF24-4B7E-91F7-DA92AB29CBDBQ35609031-77FB99C2-5D63-4703-B424-A551A3ECB0DFQ35652389-12E81730-42C4-40A7-A888-745DB9B3A652Q35967313-A5842B1B-9A57-4881-A8D3-15D2D7256695Q36248193-25DF39A5-DB5B-4A08-A1D1-E1DE42C9EB28Q36387940-0209E73C-4B30-4D11-AE18-6BED5E18EB3FQ36437378-45A02048-CD7D-4ADA-B9A0-4CAEEBD6F2D2Q36545635-4EC07491-9E2C-4CAD-B23A-F1A685B64AA1Q36545638-D54B1248-E5F1-4637-AD49-E67F5E0DE8CEQ36685435-CBF7395D-8D2B-412C-9E6C-BF77F5EEDD13Q36701474-9D6F7B40-4769-44B2-98A4-09A3C5494055Q36775413-582E8847-38E1-4759-BF59-A5C8E4C8DFADQ36810258-F195B26A-F320-41DA-8481-8FFA1A5D4C6CQ37014165-A67EE7E3-633C-47DC-B744-67D458422C95Q37027060-E81E7DB3-C033-4D6A-AA58-B16D80E9769EQ37045403-F89855FB-AFA3-49E1-B2D6-343F155CC973Q37149641-4B1B835B-7069-4914-B162-1C3D562FECF0Q37174207-C84FDCA2-0A1D-4BEB-A42F-98BD4960ABDDQ37386616-DBBE095B-5184-44E7-A3B1-0A6F37E647B0Q37607675-ED8B0829-C45D-4A0B-933E-8E9AAF598431Q37945288-36A414B1-586F-4A78-8736-D9F6810943C4
P2860
Dual cancer-specific targeting strategy cures primary and distant breast carcinomas in nude mice.
description
2005 nî lūn-bûn
@nan
2005 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Dual cancer-specific targeting ...... reast carcinomas in nude mice.
@ast
Dual cancer-specific targeting ...... reast carcinomas in nude mice.
@en
Dual cancer-specific targeting ...... reast carcinomas in nude mice.
@nl
type
label
Dual cancer-specific targeting ...... reast carcinomas in nude mice.
@ast
Dual cancer-specific targeting ...... reast carcinomas in nude mice.
@en
Dual cancer-specific targeting ...... reast carcinomas in nude mice.
@nl
prefLabel
Dual cancer-specific targeting ...... reast carcinomas in nude mice.
@ast
Dual cancer-specific targeting ...... reast carcinomas in nude mice.
@en
Dual cancer-specific targeting ...... reast carcinomas in nude mice.
@nl
P2093
P2860
P356
P1476
Dual cancer-specific targeting ...... reast carcinomas in nude mice.
@en
P2093
Devanand Sarkar
Eun Sook Park
Nicolaq Vozhilla
Pankaj Gupta
Paul B Fisher
Zao-Zhong Su
P2860
P304
14034-14039
P356
10.1073/PNAS.0506837102
P407
P577
2005-09-19T00:00:00Z